[ad_1]
AMSTERDAM – The European Medicines Agency has launched a fast-track review process to determine whether a common arthritis drug could help people hospitalized with severe COVID-19, months after the drug was approved for use. emergency in the United States
In a statement released on Monday, the European medicines regulator said it was assessing a request to extend the use of tocilizumab for adults with severe coronavirus in hospital, who were already being treated with other steroids or needed supplemental oxygen, including via a ventilator. Tocilizumab is an anti-inflammatory medicine currently used to treat adults and children with severe arthritis.
CLICK HERE FOR FULL CORONAVIRUS COVERAGE
In June, the United States Food and Drug Administration granted the drug emergency use authorization and the World Health Organization recommended its use last month for people seriously ill with COVID-19. The European regulator has said it expects to make a decision by mid-October on tocilizumab, based on data from four large studies. The medicine was first authorized in the EU in 2009.
[ad_2]
Source link